CN102933704A - 软骨祖细胞、用于细胞衍生的方案和其用途 - Google Patents

软骨祖细胞、用于细胞衍生的方案和其用途 Download PDF

Info

Publication number
CN102933704A
CN102933704A CN2011800279230A CN201180027923A CN102933704A CN 102933704 A CN102933704 A CN 102933704A CN 2011800279230 A CN2011800279230 A CN 2011800279230A CN 201180027923 A CN201180027923 A CN 201180027923A CN 102933704 A CN102933704 A CN 102933704A
Authority
CN
China
Prior art keywords
cell
cartilage
chondrocyte
substratum
dccpc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011800279230A
Other languages
English (en)
Chinese (zh)
Inventor
B·S·诺贝尔
D·M·皮尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
Original Assignee
University of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Edinburgh filed Critical University of Edinburgh
Publication of CN102933704A publication Critical patent/CN102933704A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
CN2011800279230A 2010-04-08 2011-04-08 软骨祖细胞、用于细胞衍生的方案和其用途 Pending CN102933704A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32198210P 2010-04-08 2010-04-08
US61/321,982 2010-04-08
PCT/GB2011/000547 WO2011124894A1 (en) 2010-04-08 2011-04-08 Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof

Publications (1)

Publication Number Publication Date
CN102933704A true CN102933704A (zh) 2013-02-13

Family

ID=44278973

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011800279230A Pending CN102933704A (zh) 2010-04-08 2011-04-08 软骨祖细胞、用于细胞衍生的方案和其用途

Country Status (9)

Country Link
US (2) US9029145B2 (ja)
EP (1) EP2556147B1 (ja)
JP (1) JP5926240B2 (ja)
CN (1) CN102933704A (ja)
AU (1) AU2011236653B2 (ja)
CA (1) CA2828315A1 (ja)
IL (1) IL222292A (ja)
SG (1) SG184440A1 (ja)
WO (1) WO2011124894A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105797154A (zh) * 2014-12-31 2016-07-27 中国科学院上海生命科学研究院 软骨干细胞的分离及其应用
WO2021037142A1 (en) * 2019-08-27 2021-03-04 The Third Hospital Of Hebei Medical University Multipotent joint progenitor cells, compositions and methods thereof
CN113201487A (zh) * 2021-07-06 2021-08-03 广东先康达生物科技有限公司 成软骨细胞培养基及成软骨细胞的培养方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2875125B1 (en) 2012-07-20 2018-10-24 Alfred C. Kuo Methods for producing cartilage and bone
WO2014052912A1 (en) * 2012-09-28 2014-04-03 Scripps Health Methods of differentiating stem cells into chondrocytes
WO2014070797A1 (en) 2012-10-29 2014-05-08 Scripps Health Methods of producing pluripotent stem cells from chondrocytes
US9974885B2 (en) 2012-10-29 2018-05-22 Scripps Health Methods of transplanting chondrocytes
KR20150085815A (ko) * 2012-11-15 2015-07-24 인터내셔날 스템 셀 코포레이션 인간 섬유모세포 세포의 분화
WO2016019168A1 (en) * 2014-08-01 2016-02-04 Isto Technologies, Inc. Cell expansion methods and systems
CA3016210A1 (en) 2016-02-29 2017-09-08 Rhode Island Hospital Cartilage-derived progenitor cell lines
CN111057677B (zh) * 2019-12-27 2021-08-03 浙江大学 一种软骨祖细胞培养基及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1599793A (zh) * 2001-12-07 2005-03-23 杰龙公司 人胚胎干细胞衍生的软骨细胞前体
WO2006092633A1 (en) * 2005-03-03 2006-09-08 Roslin Institute (Edinburgh) Method for differentiation of stem cells
CN101014699A (zh) * 2004-08-24 2007-08-08 富士软件株式会社 去分化型软骨细胞向软骨细胞的再分化用培养基
WO2007122233A1 (en) * 2006-04-25 2007-11-01 Vrije Universiteit Brussel Preparation of mesenchymal progenitor cells, particularly osteogenic progenitor cells
CN101589139A (zh) * 2005-10-31 2009-11-25 株式会社现代组织工学 包含获得自肋软骨的软骨细胞的人工软骨及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2197915B (en) 1986-11-19 1990-11-14 Rolls Royce Plc Improvements in or relating to fluid bearings
US5405772A (en) 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
GB9425071D0 (en) 1994-12-13 1995-02-08 Stringer Bradley M J Chondrocyte cell lines
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5869243A (en) 1996-03-05 1999-02-09 Rhode Island Hospital Immortalized hepatocytes
AU730749B2 (en) 1996-07-25 2001-03-15 Genzyme Corporation Chondrocyte media formulations and culture procedures
EP1783139B8 (en) 1996-10-01 2009-09-23 Geron Corporation Human telomerase catalytic subunit
EP0986635A4 (en) 1997-01-10 2001-11-07 Life Technologies Inc SERUM SUBSTITUTE FOR EMBRYONIC STEM CELLS
US6090622A (en) 1997-03-31 2000-07-18 The Johns Hopkins School Of Medicine Human embryonic pluripotent germ cells
AU7813998A (en) 1997-06-04 1998-12-21 Genzyme Corporation Methods for chondrocyte growth and differentiation
JP3880795B2 (ja) 1997-10-23 2007-02-14 ジェロン・コーポレーション フィーダー細胞を含まない培養物中で、霊長類由来始原幹細胞を増殖させるための方法
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US7410798B2 (en) 2001-01-10 2008-08-12 Geron Corporation Culture system for rapid expansion of human embryonic stem cells
US6617159B1 (en) 1998-11-09 2003-09-09 Consorzio Per La Gestione Del Centro Di Biotechnologie Avanzate Serum free medium for chondrocyte cells
EP1204385A1 (en) 1999-08-02 2002-05-15 Verigen Transplantation Service International (VTSI) AG Kit for chondrocyte cell transplantation
AU7445800A (en) 1999-09-27 2001-04-30 Chugai Seiyaku Kabushiki Kaisha Method of prolonging normal cell life span
CA2397292A1 (en) 2000-01-14 2001-07-19 Bresagen Limited Cell production
DE10022344C1 (de) 2000-05-08 2001-12-06 Siemens Ag Motorischer Getriebe-Verstellantrieb, insbesondere Kraftfahrzeug-Fensterheberantrieb.
US6576464B2 (en) 2000-11-27 2003-06-10 Geron Corporation Methods for providing differentiated stem cells
US20030036194A1 (en) 2001-07-06 2003-02-20 Chunhui Xu Mesenchymal cells derived from human embryonic stem cells
US20030113910A1 (en) 2001-12-18 2003-06-19 Mike Levanduski Pluripotent stem cells derived without the use of embryos or fetal tissue
US20030224411A1 (en) 2003-03-13 2003-12-04 Stanton Lawrence W. Genes that are up- or down-regulated during differentiation of human embryonic stem cells
AU2005271723B2 (en) 2004-07-13 2010-12-16 Asterias Biotherapeutics, Inc. Medium for growing human embryonic stem cells
CN101233226B (zh) 2005-06-22 2017-08-11 阿斯特利亚斯生物治疗股份公司 人胚胎干细胞的悬浮培养物
EP2247716B1 (en) 2008-01-30 2012-04-25 Geron Corporation Synthetic surfaces for culturing cells in chemically defined media
WO2009099539A2 (en) 2008-01-30 2009-08-13 Corning Incorporated (meth)acrylate surfaces for cell culture, methods of making and using the surfaces

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1599793A (zh) * 2001-12-07 2005-03-23 杰龙公司 人胚胎干细胞衍生的软骨细胞前体
CN101014699A (zh) * 2004-08-24 2007-08-08 富士软件株式会社 去分化型软骨细胞向软骨细胞的再分化用培养基
WO2006092633A1 (en) * 2005-03-03 2006-09-08 Roslin Institute (Edinburgh) Method for differentiation of stem cells
CN101589139A (zh) * 2005-10-31 2009-11-25 株式会社现代组织工学 包含获得自肋软骨的软骨细胞的人工软骨及其制备方法
WO2007122233A1 (en) * 2006-04-25 2007-11-01 Vrije Universiteit Brussel Preparation of mesenchymal progenitor cells, particularly osteogenic progenitor cells

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
SHU TAKEDA ET AL: "Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice", 《GENES DEV.》 *
WEI SEONG TOH ET AL: "Differentiation and enrichment of expandable chondrogenic cells from human embryonic stem cells in vitro", 《J. CELL. MOL. MED.》 *
同志超等: "骨髓间质干细胞体外定向诱导分化为软骨细胞的实验研究", 《中国骨伤》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105797154A (zh) * 2014-12-31 2016-07-27 中国科学院上海生命科学研究院 软骨干细胞的分离及其应用
WO2021037142A1 (en) * 2019-08-27 2021-03-04 The Third Hospital Of Hebei Medical University Multipotent joint progenitor cells, compositions and methods thereof
CN114555101A (zh) * 2019-08-27 2022-05-27 河北医科大学第三医院 多潜能关节祖细胞、其组合物及制备方法
CN113201487A (zh) * 2021-07-06 2021-08-03 广东先康达生物科技有限公司 成软骨细胞培养基及成软骨细胞的培养方法

Also Published As

Publication number Publication date
US9725697B2 (en) 2017-08-08
CA2828315A1 (en) 2011-10-13
JP5926240B2 (ja) 2016-05-25
IL222292A (en) 2016-06-30
IL222292A0 (en) 2012-12-31
EP2556147A1 (en) 2013-02-13
EP2556147B1 (en) 2018-10-03
JP2013523146A (ja) 2013-06-17
US9029145B2 (en) 2015-05-12
AU2011236653B2 (en) 2016-10-27
WO2011124894A1 (en) 2011-10-13
US20110256109A1 (en) 2011-10-20
US20150240208A1 (en) 2015-08-27
SG184440A1 (en) 2012-11-29

Similar Documents

Publication Publication Date Title
CN102933704A (zh) 软骨祖细胞、用于细胞衍生的方案和其用途
McCarthy et al. The comparison of equine articular cartilage progenitor cells and bone marrow-derived stromal cells as potential cell sources for cartilage repair in the horse
RU2409665C2 (ru) Мультипотентные стволовые клетки, полученные из жировой ткани человека, и содержащие их клеточные терапевтические агенты
KR100973453B1 (ko) 인간 배아 줄기 세포에서 유래되는 연골세포 전구체
JP2021104021A (ja) 軟骨細胞系統細胞及び／又は軟骨様組織を作製するための方法及び組成物
Danoviz et al. Skeletal muscle satellite cells: background and methods for isolation and analysis in a primary culture system
ES2535042T3 (es) Identificación y aislamiento de células multipotentes de tejido mesenquimal no osteocondral
CN104364263B (zh) 含有层粘连蛋白和钙粘蛋白的细胞培养基底
Seruya et al. Clonal population of adult stem cells: life span and differentiation potential
AU2011236653A1 (en) Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof
KR20160036031A (ko) 연골 재생용 세포 치료제
Ansari et al. Cell sources for human in vitro bone models
Chiu et al. Engineering of scaffold‐free tri‐layered auricular tissues for external ear reconstruction
US20150166960A1 (en) Method for producing functional fusion tissue
Zhou et al. Tetraploid complementation proves pluripotency of induced pluripotent stem cells derived from adipose tissue
Duan et al. Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation
JP2022061030A (ja) 幹細胞の増殖及び繁殖を促進する方法
Khan et al. Articular Cartilage Chondroprogenitors: Isolation and Directed Differentiation
Zhang et al. Osteogenic Differentiation from Induced Pluripotent Stem Cells via a Three-Dimensional Culture Method
Yeola Generating multipotent stem cells from primary human adipocytes for tissue repair
Birch et al. Two-and three-dimensional tissue culture methods for hard tissue engineering
NZ713111B2 (en) Methods and compositions for generating chondrocyte lineage cells and/or cartilage like tissue

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1182135

Country of ref document: HK

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130213